The New York-based company will use the funds to grow its team, continue expanding into health systems and accelerate product innovation.

The acquisition will see the publicly traded healthcare-navigation company become a privately held business.

Developers see a potential use of the AI-powered mobile solution for routine early skin cancer screening.

The acquisition will allow the fertility and family-building company to provide its services in more than 100 countries and in over 225 languages.

Interestingly, young physicians see more risk to it than their senior counterparts.

It has shown 82% accuracy in detecting stroke, comparable to paramedics, according to RMIT University.